|
CSDAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.9417800700694E-13 |
| Normal-vs-Stage2 |
6.02189999999725E-05 |
| Normal-vs-Stage3 |
2.17929999999367E-05 |
| Normal-vs-Stage4 |
2.344200E-03 |
| Stage1-vs-Stage2 |
2.682400E-01 |
| Stage1-vs-Stage3 |
2.564000E-01 |
| Stage1-vs-Stage4 |
4.284300E-02 |
| Stage2-vs-Stage3 |
9.406200E-01 |
| Stage2-vs-Stage4 |
6.486300E-02 |
| Stage3-vs-Stage4 |
5.352200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.16939791183768E-11 |
| Normal-vs-Asian |
1.960970E-01 |
| Caucasian-vs-AfricanAmerican |
6.355000E-03 |
| Caucasian-vs-Asian |
5.179000E-01 |
| AfricanAmerican-vs-Asian |
1.824640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.63447033685316E-12 |
| Male-vs-Female |
3.624200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.11140000003118E-06 |
| Normal-vs-Extreme_Weight |
6.93569979226538E-10 |
| Normal-vs-Obese |
8.81794637308531E-12 |
| Normal-vs-Extreme_Obese |
1.169770E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.941000E-01 |
| Normal_Weight-vs-Obese |
2.406400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.845600E-01 |
| Extreme_Weight-vs-Obese |
1.846010E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.764800E-01 |
| Obese-vs-Extreme_Obese |
1.615640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.72400000000895E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.79933845600999E-12 |
| Normal-vs-Age(81-100Yrs) |
1.339750E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.020100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.351400E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.755100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.481880E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.073180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.834800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.60910000002179E-06 |
| Normal-VS-KIRP CIMP |
1.203310E-04 |
| Normal-VS-Unclassified PRCC |
2.20829999952876E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.257300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.588900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.822200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.23510000016714E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.007620E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.180110E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.7371999995226E-07 |
| Normal-vs-N1 |
1.63649999999071E-05 |
| Normal-vs-N2 |
4.200200E-02 |
| N0-vs-N1 |
1.104130E-02 |
| N0-vs-N2 |
2.911000E-01 |
| N1-vs-N2 |
6.338000E-01 |
|
|
